Podcast

Pharmacy Focus: Psychedelic Pharmacy - Episode 3

Colonel Dallas Hack discussed the development of a novel derivative of psilocybin for the treatment of post-traumatic stress disorder

In this episode, Colonel Dallas Hack discussed the development of a novel derivative of psilocybin for the treatment of post-traumatic stress disorder, as well as how his own background led him to this research. In the interview, Hack said he believes a derivative could improve access as well as acceptance of the psychedelic drug.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Trisha Winroth, PharmD, and Ashly McPhillips, PharmD
Ashley Pugh, PharmD, and Lauren Angelo, PharmD, MBA